Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

NGEN

NERVGEN PHARMA CORP.

CIK 0001751912 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$1.86
↑ 0.10 (5.68%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BullishOverall score · based on 2/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Excluded: Fundamentals, Options (no data)

Key stats

Market Cap
$197.93M
P/E Ratio
Not covered
EPS
-0.61
Dividend Yield
Not covered
52W Position
6%
Beta
1.57

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
Not covered
P/S
Not covered
EV/Revenue
Not covered
ROE
Not covered
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

156 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 6%
$1.58$6.30

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
-$44.12M
Total Assets
$23.21M
Free Cash Flow
–

Recent news